Rare tumours and Histiocytosis

A rare condition called Langerhans cell histiocytosis (LCH) starts in LCH cells. Dendritic cells of the LCH cell type are typically used by the body to fight infection. Genes that regulate the function of dendritic cells can occasionally undergo mutations (changes). Gene mutations in the BRAF, MAP2K1, RAS, and ARAF families are among them. In some areas of the body, these mutations may cause an excessive number of LCH cells to develop and accumulate, which could lead to lesions or tissue damage.

 

    Related Conference of Rare tumours and Histiocytosis

    June 29-30, 2026

    6th Global Summit on Pediatric Nursing

    Barcelona, Spain
    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    October 05-06, 2026

    39th World Pediatrics Conference

    Madrid, Spain
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE

    Rare tumours and Histiocytosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in